KAIRE HOLDINGS INC
10QSB/A, EX-27, 2000-09-06
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: KAIRE HOLDINGS INC, 10QSB/A, 2000-09-06
Next: WASTE MANAGEMENT INC, S-8 POS, 2000-09-06



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             APR-01-2000             JAN-01-2000
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                               0                 287,226
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                 769,667
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                 315,973
<CURRENT-ASSETS>                                     0               1,433,203
<PP&E>                                               0                 252,866
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                       0               5,523,455
<CURRENT-LIABILITIES>                                0               1,508,313
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                             0                 116,093
<OTHER-SE>                                           0               2,898,239
<TOTAL-LIABILITY-AND-EQUITY>                         0               5,523,455
<SALES>                                        727,785                 788,844
<TOTAL-REVENUES>                               727,785                 788,844
<CGS>                                          464,914                 495,984
<TOTAL-COSTS>                                  352,491                 587,943
<OTHER-EXPENSES>                                38,171                 223,171
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                  14,544
<INCOME-PRETAX>                              (127,791)               (532,797)
<INCOME-TAX>                                       400                     800
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 (128,191)               (533,297)
<EPS-BASIC>                                    (0.016)                 (0.006)
<EPS-DILUTED>                                  (0.016)                 (0.006)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission